Cytogenetic Systems Market

Cytogenetic Systems Market

Cytogenetic Systems Market Global Industry Assessment & Forecast

# Pages:

180

Base Year:

2021

Nov - 2021

Format:

Report Code:

VMR-2021-0171

Segments Covered
  • By Product Flow cytometry, Fluorescence In Situ Hybridization (FISH), Multiplex- Fluorescence In Situ Hybridization (M-FISH), Comparative Genomic Hybridization (CGH)
  • By Application Genetic Disorders, Neoplastic Diseases, Personalized Medicine, Others
Snapshot
Forecast YearsForecast Years: 2022 - 2028
Historical YearsHistorical Years: 2016 - 2021
Revenue 2021Revenue 2021: 2.54 Billion
Revenue 2028: 4.45 Billion
Revenue CAGR (2022 - 2028): 8.2
Fastest Growing Region (2022 - 2028) North America
Customization Offered
  • Cross-segment Market Size and Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report
  • Go To Market Strategy
  • Region Specific Market Dynamics
  • Region Level Market Share
  • Import Export Analysis
  • Production Analysis
  • Others Request Customization Speak To Analyst

Key Insights

The global Cytogenetic Systems market was valued at USD 2.54 Billion in 2020 and is projected to reach USD 4.45 Billion by 2028, growing at a CAGR of 8.2% from 2021 to 2028.

Years Parameters
Historical Data (Actual Data) 2016-2020
Base Year Data 2020
Current Year Date 2021
Projected year data 2021-2028
Annual Market Size (2028) 4.45 Billion
Annual Market Size (2021)
CAGR (2021 - 2028) 8.2%

Overview and Description

Cytogenetics is basically a branch of genetics, although it is also a section of cell cytology/ biology, which is concerned with how the chromosomes relate to cell behaviour, especially to their behaviour during meiosis and mitosis. Techniques used involves analysis of G-banded chromosomes, karyotyping, other techniques for cytogenetic banding, as well as molecular cytogenetics like comparative genomic hybridization and fluorescent in situ hybridization.


This report provides an analysis of the Cytogenetic Systems market for the historic period of 2016–2019 and forecasts for 2021–2028 while 2020 is considered as a base year for estimations. The report includes exhaustive analysis of segments, regions and countries comprising of market size and estimations in terms of revenue for the years 2016–2028. There regional section of the report is bifurcated into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Moreover, the report also covers exhaustive information on growth factors/drivers, restraints, opportunities, regulatory landscape and technology roadmap among others. Moreover, the report also includes exhaustive SWOT analysis, PEST analysis, value chain analysis, and Porter’s five forces analysis on Cytogenetic Systems market. This data is likely to help the industry stakeholders and stimulate the decision-making process.

vantage Market img 2.54 Billion 4.45 Billion

COVID-19 Impact Analysis

The COVID-19 outbreak has affected various industries worldwide. The Cytogenetic Systems market is no exception. Governments across the world took severe actions like border seals, lockdown, and implementing strict social distancing measures, in order to stop swift spread of COVID-19. These actions led to severe impact on the global economy. Industrialist across the globe were forced to halt their production, leading to supply chain disruptions and impairing of various industries. However, it is expected that reopening of trade activities, the market will witness steady growth in demand in the coming years. The impact of COVID-19 on the market demand is considered while estimating the current and forecast market size and growth trends for all the regions and countries.


The report provides a completely separate chapter for COVID-19 Impact Analysis. This chapter includes:

o   Impact Assessment of COVID-19 Pandemic

o   Pre & Post COVID-19 Market Size

o   Qualitative analysis on the short term & long-term impact of COVID-19 on the market

o   The analysis provides foremost strategies adopted by competitors to minimize the impact of the pandemic on their business activities and scope for future developments.

Industry Analysis

Increasing demand of early diagnosis of serious diseases which are life threatening like cancer and examination of disorders owing to chromosomal anomalies in emerging embryos are the main determinants for the growth of global Cytogenetic Systems market. 

Growth of population pool especially geriatric population, increasing exposure to harmful ultraviolet rays and chemicals, rise in numbers of people adopting bad habits like drinking and smoking and the sedentary lifestyle is driving the market growth. 

Technical complexities and limitations related with the equipment, lack of knowledge with regard to advanced technological procedures particularly in middle and low income nations and huge cost of sophisticated devices are factors retraining the growth.

Global Cytogenetic Systems Market Report Scope

Parameter Details
Market Size Provided for Years 2016-2028
Base Year 2020
Historic Years 2016-2020
Forecast Years 2021-2028
Market Size Provided In Terms Of Revenue & Volume
Segments Covered Product, Application
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
Countries Covered The U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, South East Asia, Brazil, Argentina, GCC Countries, and South Africa, among others
Companies Covered ADS Biotec Inc., Genial Genetics, Laboratory Imaging s.r.o., MetaSystems, Agilent Technologies, Cytocell Ltd, Leica Biosystems Nussloch GmbH, Applied Spectral Imaging, Irvine Scientifi­c, PerkinElmer Inc., Bio-Rad Laboratories, Inc., Abbott Laboratories.
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, technology landscape, patent analysis, market attractiveness analysis by segments and North America, company market share analysis, and COVID-19 impact analysis

Market Segmentation

The report delivers an acute breakdown of the market based on various segments such as Product, Application, , and region. The report includes market size and forecast for each segment by region/country for the years 2016–2028. Moreover, it also covers a thorough analysis of growth factors and opportunities impacting segmental growth.

On the basis of Product, the market is divided into Flow cytometry, Fluorescence In Situ Hybridization (FISH), Multiplex- Fluorescence In Situ Hybridization (M-FISH), Comparative Genomic Hybridization (CGH). Flow cytometry dominated the global Cytogenetic Systems market in 2020 and is projected to witness the same trend during the forecast period.

Based on Application, the market is segmented into Genetic Disorders, Neoplastic Diseases, Personalized Medicine, Others. Genetic Disorders accounted for the highest market share and is expected to grow at a significant CAGR from 2021 to 2028. 

Global Cytogenetic Systems Market: Product Segment Analysis

    • Flow cytometry
    • Fluorescence In Situ Hybridization (FISH)
    • Multiplex- Fluorescence In Situ Hybridization (M-FISH)
    • Comparative Genomic Hybridization (CGH)

Global Cytogenetic Systems Market: Application Segment Analysis

    • Genetic Disorders
    • Neoplastic Diseases
    • Personalized Medicine
    • Others

Regional Analysis: Preview

Based on the geography, the global Cytogenetic Systems market is segmented into North America, Latin America, Asia Pacific, Europe, and the Middle East & Africa. Moreover, the regional sections if further bifurcated into key country level markets for better understanding of the market.

The report covers detailed analysis on drivers, business opportunities, regulatory norms, supplier concertation and such other factors impacting regional growth. Moreover, it also covers market estimations and forecast for each segment for each region for the years 2016–2028. 

Market Size, 2021 (USD Billion)
North America
Europe
Asia Pacific
South America
Middle East Africa

Global Cytogenetic Systems Market: Regional Analysis

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • France
    • Germany
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East and Africa
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

The global Cytogenetic Systems market report provides an exhaustive competitive landscape to give a comprehensive synopsis of the global market. Major players in the Cytogenetic Systems market are ADS Biotec Inc., Genial Genetics, Laboratory Imaging s.r.o., MetaSystems, Agilent Technologies, Cytocell Ltd, Leica Biosystems Nussloch GmbH, Applied Spectral Imaging, Irvine Scientifi­c, PerkinElmer Inc., Bio-Rad Laboratories, Inc., Abbott Laboratories..  This section of the report provides in depth analysis on key market players based on various parameters such as business overview, portfolio analysis, business strategies, financial performance, geographical presence, and recent developments among others. It will also include information on key strategies adopted by major market players. 

Global Cytogenetic Systems Market: Key Highlights

  • The global Cytogenetic Systems market was valued at USD 2.54 Billion in 2020
  • The global Cytogenetic Systems Market is projected to reach USD 4.45 Billion by 2028
  • North America held the highest share of the Cytogenetic Systems market in 2020
  • Some of the major companies operating in the Cytogenetic Systems market are ADS Biotec Inc., Genial Genetics, Laboratory Imaging s.r.o., MetaSystems, Agilent Technologies, Cytocell Ltd, Leica Biosystems Nussloch GmbH, Applied Spectral Imaging, Irvine Scientifi­c, PerkinElmer Inc., Bio-Rad Laboratories, Inc., Abbott Laboratories.

FAQ
Frequently Asked Question
  • The global Cytogenetic Systems valued at 2.54 Billion in 2020 and is expected to reach 4.45 Billion in 2028 growing at a CAGR of 8.2%.

  • The prominent players in the market are ADS Biotec Inc., Genial Genetics, Laboratory Imaging s.r.o., MetaSystems, Agilent Technologies, Cytocell Ltd, Leica Biosystems Nussloch GmbH, Applied Spectral Imaging, Irvine Scientifi­c, PerkinElmer Inc., Bio-Rad Laboratories, Inc., Abbott Laboratories..

  • The market is project to grow at a CAGR of 8.2% between 2021 and 2028.

  • The driving factors of the Cytogenetic Systems include

    • Increasing demand of early diagnosis of serious diseases which are life threatening like cancer and examination of disorders owing to chromosomal anomalies in emerging embryos are the main determinants for the growth of global Cytogenetic Systems market.
    • Growth of population pool especially geriatric population, increasing exposure to harmful ultraviolet rays and chemicals, rise in numbers of people adopting bad habits like drinking and smoking and the sedentary lifestyle is driving the market growth.

  • North America was the leading regional segment of the Cytogenetic Systems in 2020.